Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants and children. mRNA vaccines based on the lipopolyplex (LPP) platform have been previously reported, but they remain unapplied in RSV vaccine development. In this study, we developed a novel LPP-de...

Description complète

Détails bibliographiques

Auteurs principaux:	Xuchang Shan, Ruiwen Han, Xueting Cheng, Jialuo Bing, Zhenyong Qi, Shucai Sun, Tangqi Wang, Qiaohong Chu, Yao Deng, Desheng Zhai, Wenjie Tan
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-01-01
Collection:	Vaccines
Sujets:	respiratory syncytial virus prefusion protein mRNA vaccine lipopolyplex platform immune protection
Accès en ligne:	https://www.mdpi.com/2076-393X/13/1/93
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!